Prevalence, Isolation, Characterisation and Antibiogram Study of Pathogenic Escherichia coli from Different Poultry Farms of Odisha
Keywords:
Antibiogram; Escherichia coli; Farms; PoultryAbstract
From 182 birds of different farms of odisha suspected for colibacillosis 317 swab samples containing 51 air sacs, 39 lungs, 53 livers, 36 heart bloods, 45 pericardial fluids, 19 yolk sacs and 74 intestine samples were processed for isolation and identification of pathogenic E. coli. and subjected to detail bacteriological and biochemical examination in the laboratory and 105 E. coli isolates were isolated following standard procedures. The percentage of isolation of E. coli isolates in decreasing order was yolk sac (52.6%) and heart blood (38.4%) in 0-4 week birds. In older birds (4-7week) the highest percentage of isolation was from pericardial fluid (35.8%) followed by heart blood (33.4%). The present study showed that the frequency of occurrence of O9 strain is highest (16.7%) followed by O1, O33 & O51 (13.3%), O23 & O119 (10%), O103 & 79 (6.7%) and serotype O90 (3.3%). The antibiogram study reveals that, E. coli isolates found were highly resistant to some of the classical drugs like chlortetracycline (88.58%), streptomycin (85.72%), penicillin-G (82.86%), amikacin (82.86%), furazolidone (77.14%), ampicillin (74.29%), Tetracycline(74.29%), Amoxicillin (71.43%) and cotrimoxazole (71.43%), while isolates were highly sensitive to ceftriaxone and tazobactum (94.29%), ceftriaxone (91.43%), gentamicin (85.72%), chloromphenicol (82.67%), cephotaxime (77.14%), cefixime (74.29%) and ciprofloxacin (74.29%).
Downloads
Published
How to Cite
Issue
Section
License
Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles under the following conditions: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).
Attribution-NonCommercial-NoDerivs
CC BY-NC-ND
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license